Cencora Inc’s filing revealed that its Director COLLIS STEVEN H acquired Company’s shares for reported $4.23 million on Aug 19 ’25. In the deal valued at $289.98 per share,14,579 shares were bought.
Then, Mauch Robert P. bought 4,968 shares, generating $1,458,257 in total proceeds.
Before that, COLLIS STEVEN H sold 14,578 shares. Cencora Inc shares valued at $4,266,543 were divested by the Executive Chairman at a price of $292.67 per share. As a result of the transaction, COLLIS STEVEN H now holds 309,913 shares, worth roughly $91.33 million.
Wells Fargo upgraded its Cencora Inc [COR] rating to an Overweight from a an Equal weight in a research note published recently. BofA Securities also remained covering COR and has decreased its forecast on September 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners started covering the stock on February 26, 2024. It rated COR as “an Outperform”.
Price Performance Review of COR
On Tuesday, Cencora Inc [NYSE:COR] saw its stock jump 1.50% to $294.71. Over the last five days, the stock has gained 1.92%. Cencora Inc shares have risen nearly 24.52% since the year began. Nevertheless, the stocks have risen 31.17% over the past one year. While a 52-week high of $309.35 was reached on 05/07/25, a 52-week low of $218.65 was recorded on 01/02/25.
Levels Of Support And Resistance For COR Stock
The 24-hour chart illustrates a support level at 290.10, which if violated will result in even more drops to 285.50. On the upside, there is a resistance level at 297.53. A further resistance level may holdings at 300.36.
How much short interest is there in Cencora Inc?
A steep rise in short interest was recorded in Cencora Inc stocks on 2025-07-31, dropping by -0.33 million shares to a total of 6.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 6.81 million shares. There was a decline of -5.08%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $242 price target.
